Additional comments: Refer to the most recent version of the FDA guidance for industry on In Vitro Permeation Test Studies for Topical Drug Products Submitted in ANDAsa for additional information regarding the development, validation, conduct and analysis of acceptable IVPT methods/studies. The batches of test product and reference standard evaluated in the IVPT bioequivalence study should be the same as those evaluated in the IVRT bioequivalence study